focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

13 Jun 2018 11:06

RNS Number : 2740R
Sinclair Pharma PLC
13 June 2018
 

Sinclair Pharma plc

Result of AGM

 

13 June 2018, Sinclair Pharma plc (AIM: SPH.L), the international aesthetics company, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.

 

 

 

For further information, please contact:

 

Sinclair Pharma plc Tel: +44 (0) 20 7467 6920

Chris Spooner 

Alan Olby

Andy Crane

 

Peel Hunt LLP (NOMAD and Joint Broker) Tel: +44 (0) 20 7418 8900 James Steel

Oliver Jackson

 

RBC Capital Markets (Joint Broker) Tel: +44 (0) 20 7653 4000

Marcus Jackson

 

 

Media enquiries

FTI Consulting Tel: +44 (0) 20 3727 1000

Ben Atwell

Brett Pollard

 

Notes to Editors:

About Sinclair Pharma plc 

Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, self-pay global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets, Brazil, South Korea and the US, and has a network of international distributors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGFKNDKKBKDBAD
Date   Source Headline
5th Nov 20181:43 pmRNSForm 8.3 - Sinclair Pharma PLC
5th Nov 20187:30 amRNSSuspension - Sinclair Pharma Plc
5th Nov 20187:00 amRNSScheme of Arrangement becomes Effective
2nd Nov 201812:55 pmRNSPUBLIC DEALING DISCLOSURE
2nd Nov 201812:40 pmRNSPUBLIC DEALING DISCLOSURE
2nd Nov 201812:36 pmRNSRule 2.9 Announcement
2nd Nov 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
2nd Nov 20187:44 amRNSForm 8.3 - Sinclair Pharma PLC
1st Nov 20183:45 pmRNSAdditional Listing
1st Nov 20183:08 pmRNSForm 8.3 - Sinclair Pharma plc
1st Nov 201812:43 pmRNSCourt sanction of the scheme of arrangement
31st Oct 20182:25 pmRNSForm 8.3 - Sinclair Pharma plc
30th Oct 20182:29 pmRNSForm 8.3 - Sinclair Pharma plc
29th Oct 20185:30 pmRNSSinclair Pharma
29th Oct 20182:44 pmRNSForm 8.3 - Sinclair Pharma plc
29th Oct 20189:23 amRNSForm 8.3 - Sinclair Pharma Plc
29th Oct 20188:24 amRNSForm 8.3 - Sinclair Pharma PLC
26th Oct 20188:33 amRNSForm 8.3 - Sinclair Pharma PLC
25th Oct 20189:41 amRNSForm 8.3 - Sinclair Pharma PLC
24th Oct 20183:08 pmRNSForm 8.3 - SINCLAIR Pharma PLC
24th Oct 20182:39 pmRNSResults of Court Meeting and General Meeting
23rd Oct 20183:35 pmRNSForm 8.3 - Sinclair Pharma plc
23rd Oct 20182:23 pmRNSHolding(s) in Company
23rd Oct 201812:37 pmGNWMan Group PLC : Form 8.3 - Sinclair Pharma plc
22nd Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
19th Oct 20183:01 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
19th Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
19th Oct 201810:37 amRNSHolding(s) in Company
19th Oct 201810:35 amRNSHolding(s) in Company
18th Oct 20183:20 pmBUSForm 8.3 - Sinclair Pharma PLC
18th Oct 20183:15 pmRNSForm 8.3 - Sinclair Pharma plc
18th Oct 20182:59 pmBUSForm 8.3 - Sinclair Pharma plc
18th Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Oct 201811:58 amRNSForm 8.3 - Sinclair Pharma Plc
18th Oct 201811:42 amGNWMan Group PLC : Form 8.3 - Sinclair Pharma plc
18th Oct 201810:44 amRNSForm 8.3 - Sinclair Pharma Plc
18th Oct 20189:40 amRNSForm 8.3 - [LMR Partners/Sinclair Pharma]
18th Oct 20187:00 amRNSDisclosure under Rule 2.10(c)
17th Oct 20184:49 pmRNSHolding(s) in Company
17th Oct 20184:46 pmRNSHolding(s) in Company
17th Oct 20183:30 pmRNSForm 8.3 - SPH LN
17th Oct 20183:19 pmRNSForm 8.3 - Sinclair Pharma plc
17th Oct 20183:15 pmRNSForm 8.3 - Sinclair Pharma plc
17th Oct 20183:11 pmRNSForm 8.3 - Sinclair Pharma PLC
17th Oct 20183:11 pmBUSForm 8.3 - Sinclair Pharma plc
17th Oct 20182:38 pmRNSForm 8.3 - Sinclair Pharma Plc
17th Oct 201812:30 pmRNSForm 8.3 - Sinclair Pharma plc
17th Oct 201812:29 pmGNWMan Group PLC : Form 8.3 - Sinclair Pharma plc
17th Oct 201812:20 pmRNSForm 8.3 - Sinclair Pharma Plc
17th Oct 20188:06 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.